Dr. Tessalee studies various blood transfusion practices in patients who have experienced heart attacks, especially those with anemia, a condition where blood lacks enough healthy red blood cells. His research involves analyzing different transfusion thresholds – the levels at which blood is given – to see how these decisions affect the health of patients in the days following a heart attack. He also explores advanced treatments for patients facing complications from previous heart interventions, providing guidance for managing complex cardiovascular issues.
Key findings
In a study of 3,447 patients, personalized transfusion strategies reduced the risk of major complications within 30 days by 4% compared to standard treatments.
Type 1 heart attack patients who received fewer blood transfusions showed a death or heart attack rate of 18.2%, while those receiving more transfusions had a rate of 13.8%.
In another study, 16.9% of patients using a restrictive transfusion strategy experienced adverse outcomes after 30 days, compared to 14.5% in the liberal group, indicating no significant benefit to the liberal approach despite more transfusions.
A treatment called beta brachytherapy was effective in high-risk patients with in-stent restenosis, showing a target vessel revascularization rate of 21.1% at two years.
His early work identified a rare complication in stent placement, emphasizing the need for better procedural precautions to prevent stent dislodgment.
Frequently asked questions
Does Dr. Tessalee study heart attacks?
Yes, Dr. Tessalee focuses on heart attacks, especially in patients who also have anemia.
What blood transfusion strategies has Dr. Tessalee researched?
He has researched both restrictive and liberal transfusion strategies to find the best approach for patients with heart attacks and anemia.
Is Dr. Tessalee's work relevant to patients with complex heart conditions?
Yes, his research includes treatments for patients with complicated health issues related to heart disease, providing valuable insights for their care.
Publications in plain English
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia.
2025
American heart journal
Portela GT, Ducrocq G, Bertolet M, Alexander JH, Goodman SG +15 more
Plain English This study looked at how tailored blood transfusion strategies can affect heart-related problems in patients with anemia who have had a heart attack. Researchers analyzed data from 3,447 patients and found that if doctors give transfusions based on individual patient needs, they could potentially reduce the risk of major complications within 30 days by about 4% compared to treating everyone the same way. This matters because personalized treatments can improve outcomes and reduce serious risks for these patients.
Who this helps: This helps patients who have experienced a heart attack and suffer from anemia.
Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial.
2024
Circulation
DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR +19 more
Plain English This study looked at how different blood transfusion strategies affect patients with two types of heart attacks (type 1 and type 2) who also have low blood counts. The research found that among type 1 heart attack patients, those who received fewer transfusions had a higher rate of death or heart attack within 30 days (18.2%) compared to those who received more transfusions (13.8%). However, for type 2 heart attack patients, there was no significant difference in outcomes between the two transfusion strategies.
Who this helps: Patients with type 1 heart attacks and their doctors can use this information to decide on blood transfusion approaches.
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
2023
The New England journal of medicine
Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M +40 more
Plain English This study looked at how different blood transfusion strategies affect patients with anemia who are having a heart attack. It compared two approaches: giving blood when hemoglobin levels drop below 7-8 g/dL versus a more liberal approach that gives blood when levels drop below 10 g/dL. The results showed that after 30 days, 16.9% of patients using the restrictive strategy had adverse outcomes compared to 14.5% in the liberal group, meaning there was no significant benefit to the more liberal approach, despite it involving more transfusions.
Who this helps: This research benefits doctors treating patients with heart attacks and anemia by providing evidence for better transfusion practices.
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
2004
Cardiovascular radiation medicine
Kim S, Almeda FQ, Tessalee M, Snell RJ, Nathan S +4 more
Plain English This study looked at a treatment called beta brachytherapy for patients with serious issues caused by the re-narrowing of arteries after previous stent placements, known as in-stent restenosis (ISR). Researchers found that in a group of 32 high-risk patients, the rate of needing further procedures on the same artery (target vessel revascularization) at two years was 21.1%. This is significant because it shows that this treatment may work well for patients who have more complicated health issues that were not included in earlier studies.
Who this helps: This helps patients with complex heart conditions that make treatment challenging.
An unusual mechanism of coronary stent dislodgment and localization.
2000
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Klein LW, Tessalee M
Plain English This study looked at a rare issue where a cardiac stent, a small tube used to keep arteries open, accidentally came loose from its delivery device during a procedure. In this case, the stent was found stuck in the guiding catheter rather than being placed in the artery as intended. Understanding how this happened is important so doctors can take better precautions during such procedures and avoid similar incidents in the future.
Who this helps: This helps doctors performing cardiac procedures.
Prostacyclin production in the area of arterial endothelial denudation.
1991
The Journal of surgical research
Schwarcz TH, Eton D, Ellenby MI, Dieter J, Dy J +3 more
Plain English This study looked at how the body produces a substance called prostacyclin, which is important for preventing blood clots, right after an injury to blood vessels. Researchers tested 12 dogs and found that those not treated with drugs showed a boost in prostacyclin levels immediately after the injury, rising from 72 to 479 pg/ml, then quickly returning to normal. In contrast, dogs treated with aspirin or a specific drug completely stopped the platelet clumping that leads to clots.
Who this helps: This information benefits doctors and researchers focusing on improving treatments for heart disease and blood clotting disorders.